Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...

How do cutting-edge science and technology respond to ethical and legal issues when incorporated into society? These issues ...

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends technology: Should we? While genetic engineering capabilities have advanced dramatically, the ethical ...

In Argentina, equine cloning in polo is no longer a rarity. It’s now a mature industry — although ethical dilemmas ...

What does the Zero Hunger Champion Award 2025 mean to you personally, and how does it reflect Pakistan’s role in the global fight against food insecurity? Zero hunger is the second among seventeen ...

“Through CRISPR RNA optimization, we achieved around 59% editing at the TTR locus in our in vitro experiments. In the mouse ...

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

Understanding human gene function in living organisms has long been hampered by fundamental differences between species.

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for Duchenne muscular dystrophy (DMD) treatment. While adeno-associated virus ...